Technical Data
036887
IFNA1, CT (IFNA1, Interferon alpha-1/13, Interferon alpha-D)
Description:
IFNA1 is produced by macrophages, IFN-alpha have antiviral activities. Interferon stimulates the production of two enzymes: a protein kinase and an oligoadenylate synthetase.

Applications:
Suitable for use in Western Blot and ELISA. Other applications have not been tested.

Recommended Dilution:
Western Blot: 1:1000
Optimal dilutions to be determined by the researcher.

Storage and Stability:
May be stored at 4C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20C. Aliquots are stable for 12 months after receipt. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
TypeIsotypeCloneGrade
PabIgGAffinity Purified
SizeStorageShippingSourceHost
200ul-20CBlue IceHumanRabbit
Concentration:
As reported
Immunogen:
KLH-conjugated synthetic peptide mapping to a fragment of residues within amino acids 164-189 in the C-terminal region of human IFNA1, UniProt Accession #P01562.
Purity:
Purified by Protein A affinity chromatography.
Form
Supplied as a liquid in PBS, pH 7.2, 0.09% sodium azide.
Specificity:
Recognizes human IFNA1.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.
Silva, L.K., et al. Eur. J. Hum. Genet. 18(11):1221-1227(2010) Schuurhof, A., et al. Pediatr. Pulmonol. 45(6):608-613(2010) Davila, S., et al. Genes Immun. 11(3):232-238(2010) Siezen, C.L., et al. Pediatr. Infect. Dis. J. 28(4):333-335(2009) Janssen, R., et al. J. Infect. Dis. 196(6):826-834(2007)